Elan Corp Plc
—- Market cap
- —
- Debt
- +$904.20M
- Cash
- −$599.20M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: Elan Corp Plc stock price vs LEGN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LEGN's multiple
Needs Revenue / share.
Implied fair value · at Elan Corp Plc's multiple
Needs Elan Corp Plc P/S.
Engine logicElan Corp Plcvalued onLEGN’smultiple
Metric by metric
Where each company leads, and how wide the gap is.
Snapshot Sep 4, 4:00 PM ET
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: Elan Corp Plc FY 2012 (ended Dec 31, 2012) · LEGN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 85% equity / 15% debt · EV / Revenue 3.69x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ELAN CORP PLC · implied price per share
The ordinary-share to listed-security ratio could not be verified.
Legend Biotech Corp · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.46x
—
Net debt / EBITDA
Leverage against operating earnings
-0.64x
0.64x
Cash and equivalents
Liquid reserves on the balance sheet
$599.20M
$901.90M
Total debt
Interest-bearing obligations outstanding
$904.20M
$711.40M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.